Form 4 for TXG 10x Genomics, Inc.
Accepted 2021-12-09 00:00:00 ET · period of report 2021-12-07 · accession 0001567619-21-021857 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-12-09 | 2021-12-07 | TXG | Saxonov Serge | CEO, Dir | M - OptEx | $7.41 | +8,246 | 892.9K | +0.9% | +$61.1K |
| DM | 2021-12-09 | 2021-12-07 | TXG | Saxonov Serge | CEO, Dir | S - Sale+OE | $145.97 | -15.0K | 888.7K | -2% | -$2.19M |
| DM | 2021-12-09 | 2021-12-07 | TXG | Saxonov Serge | CEO, Dir | M - OptEx | $0.00 | -8,246 | 53.3K | -13% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2021-12-07 | M | A | 5,209 | $5.04 | 889,818 | D | — | — | |
| 2 | Common | Class A Common Stock | 2021-12-07 | M | A | 3,037 | $11.48 | 892,855 | D | — | — | |
| 3 | Common | Class A Common Stock | 2021-12-07 | S | D | 200 | $138.86 | 892,655 | D | — | — | |
| 4 | Common | Class A Common Stock | 2021-12-07 | S | D | 766 | $142.40 | 891,889 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $141.77 to $142.59. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 5 | Common | Class A Common Stock | 2021-12-07 | S | D | 754 | $148.60 | 877,855 | D | — | — | (F8) This transaction was executed in multiple trades at prices ranging from $148.545 to $148.74. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 6 | Common | Class A Common Stock | 2021-12-07 | S | D | 672 | $144.27 | 888,030 | D | — | — | (F4) This transaction was executed in multiple trades at prices ranging from $144.00 to $144.58. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 7 | Common | Class A Common Stock | 2021-12-07 | S | D | 571 | $145.79 | 887,459 | D | — | — | (F5) This transaction was executed in multiple trades at prices ranging from $145.34 to $146.33. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 8 | Common | Class A Common Stock | 2021-12-07 | S | D | 6,480 | $147.05 | 880,979 | D | — | — | (F6) This transaction was executed in multiple trades at prices ranging from $146.45 to $147.42. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 9 | Common | Class A Common Stock | 2021-12-07 | S | D | 2,370 | $147.96 | 878,609 | D | — | — | (F7) This transaction was executed in multiple trades at prices ranging from $147.4621 to $148.38. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 10 | Common | Class A Common Stock | 2021-12-07 | S | D | 3,187 | $143.36 | 888,702 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $142.86 to $143.85. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 11 | Derivative | Stock Option (right to buy) | 2021-12-07 | M | D | 3,037 | $0.00 | 48,596 | D | $11.48 · — to 2029-05-10 | 3,037 Class A Common Stock | (F12) This option, originally for 145,786 shares, of which 97,190 have been exercised, vested as to 1/48th of the shares on May 1, 2019, and 1/48th of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date. |
| 12 | Derivative | Stock Option (right to buy) | 2021-12-07 | M | D | 5,209 | $0.00 | 53,323 | D | $5.04 · — to 2028-11-02 | 5,209 Class A Common Stock | (F11) This option, originally for 250,000 shares, of which 196,677 have been exercised, vested as to 1/48th of the shares on October 1, 2018, and 1/48th of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date. |